Priority list of research areas for radiological nuclear threat countermeasures

Radiation Research

Volumn 163, Issue 1, 2005, Pages 115-123

  Pellmar, Terry C ^a,c,d   Rockwell, Sara ^b   Hatchett, Richard ^d   Jarrett, David G ^d   Alexander, George ^e   Blakely, William F ^d   Brook, Itzhak ^d   Claypool, Robert ^f   Coleman, Norman ^e   Goans, Ronald E ^g   Gootenberg, Joseph ^h   Hughes, Earl ^d   Koenig, Kristi ^f   Leissa, Brad ^h   Lowry, Patrick ^d   Mettler, Fred ⁱ   Milligan, Patricia ^j   Noska, Michael A ^h   Pesik, Nicki ^k   Ricks, Robert C ^d   Schimmerling, Walter ^l   Seed, Thomas M ^d   Sizemore, Tom ^f   Smith, James M ^k   Swartsel, Katherine ^f   Tsu, Horace ^d   Weiss, Joseph ^d   Yeskey, Kevin ^d   Dickerson, William ^d   Prasanna, Pataje G S ^d   more..

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^d Dept of Health and Human Service ^*  (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f DEPARTMENT OF VETERANS AFFAIRS   (United States)

^g TULANE UNIVERSITY   (United States)

^h CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

ⁱ UNIVERSITY OF NEW MEXICO   (United States)

^j U S NUCLEAR REGULATORY COMMISSION   (United States)

^k CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^l NASA HEADQUARTERS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANDROSTENEDIOL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIINFECTIVE AGENT; CAPTOPRIL; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GENISTEIN; ISOFLAVONE; KERATINOCYTE GROWTH FACTOR; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 11; STEM CELL FACTOR; THROMBOPOIETIN;

ATOMIC BOMB; CARCINOGENESIS; CONFERENCE PAPER; DISEASE MARKER; DNA DAMAGE; DOSIMETRY; EXPERIMENTAL MODEL; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; INFECTION; INTERPERSONAL COMMUNICATION; KIDNEY DISEASE; MEDICAL EDUCATION; MEDICAL RESEARCH; NONHUMAN; NUCLEAR ACCIDENT; ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RISK ASSESSMENT; STEM CELL; TERRORISM; TISSUE INJURY; TRAINING;

GUIDELINES; HEALTH PHYSICS; HUMANS; NUCLEAR WARFARE; ORGANIZATIONAL OBJECTIVES; RADIATION INJURIES; RADIATION PROTECTION; RESEARCH; SECURITY MEASURES; TERRORISM; UNITED STATES;

EID: 19944401152     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3283     Document Type: Conference Paper

References (42)

1. C. N. Coleman, W. F. Blakely, J. R. Fike, T. J. MacVittie, N. F. Metting, J. B. Mitchell, J. E. Moulder, R. J. Preston, T. M. Seed and R. S. Wong, Molecular and Cellular Biology of Moderate-Dose (1-10 Gy) Radiation and Potential Mechanisms of Radiation Protection: Report of a workshop at Bethesda, Maryland, December 17-18, 2001. Radiat. Res. 159, 812-834 (2003).
2. C. N. Coleman, H. B. Stone, G. A. Alexander, M. H. Barcellos-Hoff, J. S. Bedford, R. G. Bristow, J. R. Dynlacht, Z. Fuks, L. S. Gorelic and E. M. Zeman, Education and Training for Radiation Scientists: Radiation Research Program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12-14, 2003. Radiat Res. 160, 729-737 (2003).
3. H. B. Stone, W. H. McBride and C. N. Coleman, Modifying Normal Tissue Damage Postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland, September 6-8, 2000. Radiat Res. 157, 204-223 (2002).
4. J. K. Waselenko, T. J. MacVittie, W. F. Blakely, N. Pesik, A. L. Wiley, W. E. Dickerson, H. Tsu, D. L. Confer, C. N. Coleman and T. Seed, Medical management of the acute radiation syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group. Ann. Intern. Med. 140, 1037-1051 (2004).
5. C. R. Culy and C. M. Spencer, Amifostine: An update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs 61, 641-684 (2001).
6. M. H. Whitnall, T. B. Elliott, R. A. Harding, C. E. Inal, M. R. Landauer, C. L. Wilhelmsen, L. McKinney, V. L. Miner, W. E. Jackson 3rd and T. M. Seed, Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Int. J. Immunopharmacol. 22, 1-14 (2000).
7. M. H. Whitnall, C. L. Wilhelmsen, L. McKinney, V. Miner, T. M. Seed and W. E. Jackson 3rd, Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice. Immunopharmacol. Immunotoxicol. 24, 595-626 (2002).
8. K. S. Kumar, V. Srinivasan, R. Toles, L. Jobe and T. M. Seed, Nutritional approaches to radioprotection: Vitamin E. Mil. Med. 167 (Suppl. 2), 57-59 (2002).
9. M. R. Landauer, V. Srinivasan and T. M. Seed, Genistein treatment protects mice from ionizing radiation injury. J. Appl. Toxicol. 23, 379-385 (2003).
10. J. F. Weiss and M. R. Landauer, Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 189, 1-20 (2003).
11. J. E. Moulder, Post-irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: A review. Int. J. Radiat. Biol. 80, 1-8 (2004).
12. H. B. Stone, J. E. Moulder, C. N. Coleman, K. K. Ang, M. S. Anscher, M. H. Barcellos-Hoff, W. S. Dynan, J. R. Fike, D. J. Grdina and D. Zaharevitz, Models for Evaluating Agents Intended for the Prophylaxis, Mitigation and Treatment of Radiation Injuries. Report of an NCI workshop, December 3-4, 2003. Radiat. Res. 162, 711-728 (2004).
13. I. Brook, R. I. Walker and T. J. MacVittie, Effect of antimicrobial therapy on bowel flora and bacterial infection in irradiated mice. Int. J. Radiat. Biol. 53, 709-716 (1988).
14. I. Brook, T. B. Elliott, G. D. Ledney, M. O. Shoemaker and G. B. Knudson, Management of postirradiation infection: Lessons learned from animal models. Mil. Med. 169, 194-197 (2004).
15. T. J. MacVittie and A. M. Farese, Cytokine-based treatment for acute radiation-induced myelosuppression: Preclinical and clinical perspective. In The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (R. C. Ricks, M. E. Berger and F. M. O'Hara, Eds.), pp. 53-72. Parthenon, Boca Raton, FL, 2002.
16. C. E. Dunbar, M. Takatoku and R. E. Donahue, The impact of ex vivo cytokine stimulation on engraftment of primitive hematopoietic cells in a non-human primate model. Ann. NY Acad. Sci. 938, 236-244 (2001).
17. F. Herodin, P. Bourin, J. F. Mayol, J. J. Lataillade and M. Drouet, Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma-irradiation promotes survival. Blood 101, 2609-2616 (2003).
18. M. A. Mouthon, A. Van der Meeren, M. H. Gaugler, T. P. Visser, C. Squiban, P. Gourmelon and G. Wagemaker, Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 43, 867-875 (1999).
19. K. M. Zsebo, K. A. Smith, C. A. Hartley, M. Greenblatt, K. Cooke, W. Rich and I. K. McNiece, Radioprotection of mice by recombinant rat stem cell factor. Proc. Natl. Acad. Sci. USA 89, 9464-9468 (1992).
20. C. L. Farrell, J. V. Bready, K. L. Rex, J. N. Chen, C. R. DiPalma, K. L. Whitcomb, S. Yin, D. C. Hill, B. Wiemann and D. L. Lacey, Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res. 58, 933-939 (1998).
21. E. S. Yi, S. T. Williams, H. Lee, D. M. Malicki, E. M. Chin, S. Yin, J. Tarpley and T. R. Ulich, Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am. J. Pathol. 149, 1963-1970 (1996).
22. W. H. McBride, C-S. Chiang, J. L. Olson, C-C. Wang, J-H. Hong, F. Pajonk, G. J. Dougherty, K. S. Iwamoto, M. Pervan and Y-P. Liao, A sense of danger from radiation. Radiat. Res. 162, 1-19 (2004).
23. J. E. Moulder, B. L. Fish and E. P. Cohen, ACE inhibitors and All receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy. Curr. Pharm. Des. 9, 737-749 (2003).
24. S. Delanian, R. Porcher, S. Balla-Mekias and J. L. Lefaix, Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J. Clin. Oncol. 21, 2545-2550 (2003).
25. W. F. Blakely, A. L. Brooks, R. S. Lofts, G. P. van der Schans and P. Voisin, Overview of low-level radiation exposure assessment: Biodosimetry. Mil. Med. 167 (Suppl. 2), 20-24 (2002).
26. R. Kanda, Improvement of accuracy of chromosome aberration analysis for biological radiation dosimetry. J. Radiat. Res. (Tokyo) 41, 1-8 (2000).
27. J. D. Tucker, FISH cytogenetics and the future of radiation biodosimetry. Radiat. Prot. Dosim. 97, 55-60 (2001).
28. P. Dent, A. Yacoub, J. Contessa, R. Caron, G. Amorino, K. Valerie, M. P. Hagan, S. Grant and R. Schmidt-Ullrich, Stress and radiation-induced activation of multiple intracellular signaling pathways, Radiat. Res. 159, 283-300 (2003).
29. S. Rockwell, Training in the radiation sciences: A national and international need. Radiat. Res. 159, 703-704, (2003). [editorial]
30. P. Kumar and G. C. Jagetia, A review of triage and management of burn victims following a nuclear disaster. Burns 20, 397-402 (1994).
31. T. C. Pellmar, Effects of radiation in combination with biological or chemical warfare agents. In Public Protection from Nuclear, Chemical, and Biological Terrorism. (A. Brodsky, R. H. Johnson, Jr. and R. E. Goans, Eds.), pp. 503-511. Medical Physics Publishing, Madison, WI, 2004.
32. R. C. Ricks, M. E. Berger, E. C. Holloway and R. E. Goans, REAC/TS radiation accident registry: Update of accidents in the United States, 2000. Available online at http://www.irpa.net/irpa10/cdrom/00325.pdf.
33. National Research Council, Committee on the Biological Effects of Ionizing Radiation, Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V). National Academy Press, Washington, DC, 1990.
34. A. Baranov, R. P. Gale, A. Guskova, E. Piatkin, G. Selidovkin, L. Muravyova, R. E. Champlin, N. Danilova, L. Yevseeva and L. Petrosyan, Bone marrow transplantation after the Chernobyl nuclear accident. N. Engl. J. Med. 321, 205-212 (1989).
35. C. A. Salter, Psychological effects of nuclear and radiological warfare. Mil. Med. 166 (Suppl.), 17-18 (2001).
36. NCRP, Management of Terrorist Events Involving Radioactive Materials, pp. 54-73. Report No. 138, National Council on Radiation Protection and Measurements, Bethesda, MD, 2001.
37. D. J. Grdina, Y. Kataoka and J. S. Murley, Amifostine: Mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol. Drug Interact. 16, 237-279 (2000).
38. J. B. Mitchell and M. C. Krishna, Nitroxides as radiation protectors. Mil. Med. 167 (Suppl. 2), 49-50 (2002).
39. D. L. Preston, Y. Shimizu, D. A. Pierce, A. Suyama and K. Mabuchi, Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997 Radiat. Res. 160, 381-407 (2003).
40. S. A. Belinsky, D. M. Klinge, K. C. Liechty, T. H. March, T. Kang, F. D. Gilliland, N. Sotnic, G. Adamova, G. Rusinova and V. Telnov, Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. Carcinogenesis 25, 1063-1067 (2004).
41. R. Kanda, M. Minamihisamatsu and I. Hayata, Dynamic analysis of chromosome aberrations in three victims of the Tokai-mura criticality accident. Int. J. Radiat. Biol. 78, 857-862 (2002).
42. C. Streffer, R. Shore, G. Konermann, A. Meadows, P. Uma Devi, J. P. Withers, L. E. Holm, J. Stather and K. H. R. Mabuchi, Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiological Protection. Ann. ICRP 33, 5-206 (2003).